Saturday, January 25 (15)

5:00 PM - 6:00 PM

Round Table of Advanced Neuromodulation Cases

This session will present case studies on challenging neuromodulation cases with a group discussion on best practices and learning points associated with each case. On- and off-label use of neuromodulation devices will be discussed. Will include interactive audience discussion for each case using an audience response system.

Venue:
Caesars Palace
Speaker:

Stephanie G. Vanterpool, MD MBA

3:30 PM - 5:00 PM

Emerging Mechanisms of Neuromodulation: From Cellular to Network Substrates Featured

This session will focus on the current state-of-art about the mechanisms of action underlying neuromodulation in providing therapeutic efficacy. Speakers will present current knowledge on various modalities of neuromodulation involving electrical deep brain stimulation to non-invasive ultrasound and their ability and scope to alter expression and/or activity of substrates spanning molecules, cells to neural circuits. The information will help to provide a more comprehensive perspective about affected substrates from neuromodulation. Knowledge arising from this synopsis can be leveraged to optimize, personalize and/or further innovate neuromodulation efficacy.

Venue:
Caesars Palace
Speaker:

Damian S. Shin, MSc PhD

Marom Bikson, PhD

3:30 PM - 5:00 PM

Spinal Cord Stimulation Programming: Opening the Blackbox

This session will examine the implications of Spinal Cord Stimulation (SCS) programming by industry and physicians on individual patient experience and overall clinical outcomes.  We will review the basics of SCS programming. We will discuss industry and physician training regarding SCS training.  We will review SCS programming in major landmark studies and requirements for SCS programming in clinical trials.

3:30 PM - 5:00 PM

Emerging Role of Neuromodulation for Cancer Pain

Neuromodulation therapies including intrathecal pumps, spinal cord and peripheral nerve stimulators can be excellent choices for patients with cancer-related pain. Improving survival rates and duration of patients with cancer pain are allowing consideration of these therapies more frequently than in the past. Cancer patients are a unique population with some specific needs such as frequent imaging that can impact on the choice for neuromodulation therapies in this group.

Venue:
Caesars Palace
Speaker:

Amitabh Gulati, MD

Jill Sindt, MD

Subscribe to this RSS feed